BioMed X - the best of two worlds in one Institute
@biomedx.bsky.social
We accelerate the pace of innovation in biomedical research and drug discovery & development by combining the best of both worlds – academia and industry. Our innovation model:
https://pubmed.ncbi.nlm.nih.gov/39235485/
https://pubmed.ncbi.nlm.nih.gov/39235485/
Pinned
New Call for Applications! Shaping the future of #women’s #health 🚀
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession! 🧬
An online #webinar to learn more about our open Call for Application for a new collaborative research project with AbbVie about: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Save the date for the exciting #discussion and career #opportunities in neuroscience!
An online #webinar to learn more about our open Call for Application for a new collaborative research project with AbbVie about: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Save the date for the exciting #discussion and career #opportunities in neuroscience!
December 4, 2025 at 2:31 PM
𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession! 🧬
An online #webinar to learn more about our open Call for Application for a new collaborative research project with AbbVie about: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Save the date for the exciting #discussion and career #opportunities in neuroscience!
An online #webinar to learn more about our open Call for Application for a new collaborative research project with AbbVie about: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Save the date for the exciting #discussion and career #opportunities in neuroscience!
📢 Call for Application 📢 Join BioMed X and AbbVie in Advancing Neuroscience Research
We invite you to join our next collaborative research project: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Discover more about the research project in our Career Space: career.bmedx.com/call/2025-NH...
We invite you to join our next collaborative research project: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Discover more about the research project in our Career Space: career.bmedx.com/call/2025-NH...
November 25, 2025 at 10:19 AM
📢 Call for Application 📢 Join BioMed X and AbbVie in Advancing Neuroscience Research
We invite you to join our next collaborative research project: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Discover more about the research project in our Career Space: career.bmedx.com/call/2025-NH...
We invite you to join our next collaborative research project: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Discover more about the research project in our Career Space: career.bmedx.com/call/2025-NH...
📢 𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession!
BioMed X Institute invites you to a webinar to learn more about the open Call for Applications for the first XFem Labs research project: “𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐅𝐞𝐦𝐚𝐥𝐞-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐨𝐧.”
Register now:
us02web.zoom.us/webinar/regi...
BioMed X Institute invites you to a webinar to learn more about the open Call for Applications for the first XFem Labs research project: “𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐅𝐞𝐦𝐚𝐥𝐞-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐨𝐧.”
Register now:
us02web.zoom.us/webinar/regi...
November 5, 2025 at 9:14 AM
📢 𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession!
BioMed X Institute invites you to a webinar to learn more about the open Call for Applications for the first XFem Labs research project: “𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐅𝐞𝐦𝐚𝐥𝐞-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐨𝐧.”
Register now:
us02web.zoom.us/webinar/regi...
BioMed X Institute invites you to a webinar to learn more about the open Call for Applications for the first XFem Labs research project: “𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐅𝐞𝐦𝐚𝐥𝐞-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐨𝐧.”
Register now:
us02web.zoom.us/webinar/regi...
🚨 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀: 𝗕𝗶𝗼𝗠𝗲𝗱 𝗫 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗥&𝗗 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗼𝗿 𝗶𝗻 𝗛𝗲𝗶𝗱𝗲𝗹𝗯𝗲𝗿𝗴
The first initiative supported by the Gates Foundation. Discover our first research project here: bmedx.com/news-events/...
Don't miss the chance to shape the #future of women’s health! We're excited about your ideas💡
The first initiative supported by the Gates Foundation. Discover our first research project here: bmedx.com/news-events/...
Don't miss the chance to shape the #future of women’s health! We're excited about your ideas💡
October 15, 2025 at 7:45 AM
🚨 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀: 𝗕𝗶𝗼𝗠𝗲𝗱 𝗫 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗥&𝗗 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗼𝗿 𝗶𝗻 𝗛𝗲𝗶𝗱𝗲𝗹𝗯𝗲𝗿𝗴
The first initiative supported by the Gates Foundation. Discover our first research project here: bmedx.com/news-events/...
Don't miss the chance to shape the #future of women’s health! We're excited about your ideas💡
The first initiative supported by the Gates Foundation. Discover our first research project here: bmedx.com/news-events/...
Don't miss the chance to shape the #future of women’s health! We're excited about your ideas💡
New Call for Applications! Shaping the future of #women’s #health 🚀
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
October 14, 2025 at 7:47 AM
New Call for Applications! Shaping the future of #women’s #health 🚀
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
🚨 New episode of #VoicesOfBioMedX! 🎙️
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...
Day in the life of a Research Assistant | Elizaveta Savochkina | Voices of BiomedX EP 06
YouTube video by BioMed X Institute
www.youtube.com
September 29, 2025 at 10:01 AM
🚨 New episode of #VoicesOfBioMedX! 🎙️
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...
Join us at @events.embl.org Heidelberg for an inspiring #webinar with Christian Tidona, Founder and Managing Director of BioMed X Institute 🎙
📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom
🕚 October 10th, 2025 | 11:00 – 12:00 (CEST)
👉 Register here: embl-org.zoom.us/webinar/regi...
📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom
🕚 October 10th, 2025 | 11:00 – 12:00 (CEST)
👉 Register here: embl-org.zoom.us/webinar/regi...
September 24, 2025 at 3:24 PM
Join us at @events.embl.org Heidelberg for an inspiring #webinar with Christian Tidona, Founder and Managing Director of BioMed X Institute 🎙
📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom
🕚 October 10th, 2025 | 11:00 – 12:00 (CEST)
👉 Register here: embl-org.zoom.us/webinar/regi...
📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom
🕚 October 10th, 2025 | 11:00 – 12:00 (CEST)
👉 Register here: embl-org.zoom.us/webinar/regi...
New Call for Application! Reimagining drug delivery 🚀
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
August 19, 2025 at 9:03 AM
New Call for Application! Reimagining drug delivery 🚀
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
🚨 New episode of #VoicesOfBioMedX! 🎙️
Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
August 12, 2025 at 10:30 AM
🚨 New episode of #VoicesOfBioMedX! 🎙️
Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
💡 New Call for Application: BioMed X & #Servier
are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...
are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...
July 9, 2025 at 2:06 PM
💡 New Call for Application: BioMed X & #Servier
are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...
are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...
Reposted by BioMed X - the best of two worlds in one Institute
A day well spent at the 2nd Life Sciences Postdoc Symposium. Thank you to our speakers Christian Tidona @biomedx.bsky.social, Eckhard Thines @unimainz.bsky.social, Marie-Theres Weil #BioNTech & Verawan Boonsanay-Michel #sanofi for their inspiring contributions. And of course to all our participants!
June 27, 2025 at 12:39 PM
A day well spent at the 2nd Life Sciences Postdoc Symposium. Thank you to our speakers Christian Tidona @biomedx.bsky.social, Eckhard Thines @unimainz.bsky.social, Marie-Theres Weil #BioNTech & Verawan Boonsanay-Michel #sanofi for their inspiring contributions. And of course to all our participants!
Info Session on “New Platform for Next-Generation Intraocular Biologics" in partnership with #Boehringer #Ingelheim Call! Available positions for this call include: 1 Group Leader, 2 Postdoctoral Researchers, and 2 Research Assistants
us02web.zoom.us/webinar/regi...
us02web.zoom.us/webinar/regi...
June 12, 2025 at 10:57 AM
Info Session on “New Platform for Next-Generation Intraocular Biologics" in partnership with #Boehringer #Ingelheim Call! Available positions for this call include: 1 Group Leader, 2 Postdoctoral Researchers, and 2 Research Assistants
us02web.zoom.us/webinar/regi...
us02web.zoom.us/webinar/regi...
Are you a U.S.-based academic PI who lost (or may lose) #NIHfunding? 🧠 Apply for #XBridge by @BioMed_X — a new way to continue your research in a fully funded pharma–academia setting in 🇩🇪 Heidelberg or 🇺🇸 New Haven.
🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch
🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch
June 5, 2025 at 4:06 PM
Are you a U.S.-based academic PI who lost (or may lose) #NIHfunding? 🧠 Apply for #XBridge by @BioMed_X — a new way to continue your research in a fully funded pharma–academia setting in 🇩🇪 Heidelberg or 🇺🇸 New Haven.
🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch
🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch
Reposted by BioMed X - the best of two worlds in one Institute
📢 Don't miss tomorrow's seminar: 'Tracing mitochondrial Dysfunction Signatures in Aging and Autoimmunity', by Dr Gorjana Rackov from the BioMed X Institute, Heidelberg (@biomedx.bsky.social), Germany.
🗓️ 30 May
🕛 12:00
📍 CNB Lecture Hall #CNB_CSIC
🗓️ 30 May
🕛 12:00
📍 CNB Lecture Hall #CNB_CSIC
May 29, 2025 at 2:35 PM
📢 Don't miss tomorrow's seminar: 'Tracing mitochondrial Dysfunction Signatures in Aging and Autoimmunity', by Dr Gorjana Rackov from the BioMed X Institute, Heidelberg (@biomedx.bsky.social), Germany.
🗓️ 30 May
🕛 12:00
📍 CNB Lecture Hall #CNB_CSIC
🗓️ 30 May
🕛 12:00
📍 CNB Lecture Hall #CNB_CSIC
@BioMedXInst & @Boehringer invite researchers to develop next-gen intraocular biologics at #XSeedLabs (CT, USA) to reduce the burden of frequent injections in #retinal disease.
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
BioMed X Institute
BioMed X Application System
career.bmedx.com
May 22, 2025 at 11:24 AM
@BioMedXInst & @Boehringer invite researchers to develop next-gen intraocular biologics at #XSeedLabs (CT, USA) to reduce the burden of frequent injections in #retinal disease.
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
We’re launching our first collaboration with Daiichi Sankyo Co., Ltd. on "New Strategies for Targeting Solid Tumors with Multi-Specific Biologics". Boot camp kicks off in Heidelberg—welcome to our partners & participants!
🔗 bmedx.com/news-events/...
🔗 bmedx.com/news-events/...
May 12, 2025 at 4:02 PM
We’re launching our first collaboration with Daiichi Sankyo Co., Ltd. on "New Strategies for Targeting Solid Tumors with Multi-Specific Biologics". Boot camp kicks off in Heidelberg—welcome to our partners & participants!
🔗 bmedx.com/news-events/...
🔗 bmedx.com/news-events/...
🎉Congratulations to our #PTA Team on receiving three 𝐄𝐅𝐈𝐒-𝐄𝐉𝐈 𝐘𝐨𝐮𝐧𝐠 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐠𝐚𝐭𝐨𝐫 𝐓𝐫𝐚𝐯𝐞𝐥 𝐀𝐰𝐚𝐫𝐝𝐬 at the 4th #Resolution #Days Meeting in Frankfurt!
May 8, 2025 at 2:32 PM
🎉Congratulations to our #PTA Team on receiving three 𝐄𝐅𝐈𝐒-𝐄𝐉𝐈 𝐘𝐨𝐮𝐧𝐠 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐠𝐚𝐭𝐨𝐫 𝐓𝐫𝐚𝐯𝐞𝐥 𝐀𝐰𝐚𝐫𝐝𝐬 at the 4th #Resolution #Days Meeting in Frankfurt!
🌉 Today we launch #XBridge: a unique matchmaking program for U.S. researchers hit by #NIH #funding gaps.
We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r...
Not a grant—an opportunity to keep science moving.
#StandUpForScience 🔬
We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r...
Not a grant—an opportunity to keep science moving.
#StandUpForScience 🔬
April 8, 2025 at 7:57 AM
🌉 Today we launch #XBridge: a unique matchmaking program for U.S. researchers hit by #NIH #funding gaps.
We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r...
Not a grant—an opportunity to keep science moving.
#StandUpForScience 🔬
We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r...
Not a grant—an opportunity to keep science moving.
#StandUpForScience 🔬
We are excited to announce that @johnmlindner.bsky.social , our Head of Immunology Discovery & Head of Research USA, will be introducing T-FINDER at the 6th TCR-Based Therapies Summit in Boston on Wednesday, April 2, 2025.
#precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...
#precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...
March 31, 2025 at 11:42 AM
We are excited to announce that @johnmlindner.bsky.social , our Head of Immunology Discovery & Head of Research USA, will be introducing T-FINDER at the 6th TCR-Based Therapies Summit in Boston on Wednesday, April 2, 2025.
#precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...
#precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...
🔬 Advancing AI in Drug Development: BioMed X Institute at #ICLR2025 integrating #ComputationalBiology, and #KnowledgeGraphs, and #AgenticAI to transform drug development and clinical translation. Congratulations Team VPE!
March 21, 2025 at 11:08 AM
🔬 Advancing AI in Drug Development: BioMed X Institute at #ICLR2025 integrating #ComputationalBiology, and #KnowledgeGraphs, and #AgenticAI to transform drug development and clinical translation. Congratulations Team VPE!
Our Group Leader, Kyungbo Kim, at 2025 China International Biotechnology Conference in Beijing (April 16-18, 2025)!Novel approach transporting complex macromolecules, even micron-sized bacteria across the intestinal epithelium, by harnessing gut immune cells. nbc2025.eventscribe.net/index.asp?pr...
March 18, 2025 at 10:20 AM
Our Group Leader, Kyungbo Kim, at 2025 China International Biotechnology Conference in Beijing (April 16-18, 2025)!Novel approach transporting complex macromolecules, even micron-sized bacteria across the intestinal epithelium, by harnessing gut immune cells. nbc2025.eventscribe.net/index.asp?pr...
🔬 The Diary of a Scientist: A Webinar Series on Careers in Science 🎙️What does it really take to build a career in science? How do you navigate the transition between academia and industry? Register for free: webinar! us02web.zoom.us/webinar/regi...
March 12, 2025 at 6:27 PM
🔬 The Diary of a Scientist: A Webinar Series on Careers in Science 🎙️What does it really take to build a career in science? How do you navigate the transition between academia and industry? Register for free: webinar! us02web.zoom.us/webinar/regi...
Deadline extended! You have time to submit your proposal until TOMORROW March 11th!
🚨 New Call for Application Alert! 🚨
💡 Project Title: New Strategies for Targeting of Solid Tumors with Multi-Specific Biologics (MTT)
🤝In collaboration with Daiichi Sankyo
🌍Location: Heidelberg
🗓️Apply by: March 9, 2025
📍Innovation Boot Camp: May 12-16, 2025
🔗Apply here: career.bio.mx/call/2025-BM...
💡 Project Title: New Strategies for Targeting of Solid Tumors with Multi-Specific Biologics (MTT)
🤝In collaboration with Daiichi Sankyo
🌍Location: Heidelberg
🗓️Apply by: March 9, 2025
📍Innovation Boot Camp: May 12-16, 2025
🔗Apply here: career.bio.mx/call/2025-BM...
March 10, 2025 at 1:00 PM
Deadline extended! You have time to submit your proposal until TOMORROW March 11th!
🚀 𝗡𝗘𝗪 𝗖𝗮𝗹𝗹: 𝗦𝘁𝗮𝗿𝘁 𝗬𝗼𝘂𝗿 𝗢𝘄𝗻 𝗔𝗜-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗶𝗻 𝗜𝘀𝗿𝗮𝗲𝗹!🔹 We are looking for:
🧑🔬 𝟭 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝟮 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗖𝗼-𝗙𝗼𝘂𝗻𝗱𝗲𝗿𝘀 – Experts in computational biology, ML, bioinformatics, language models, encryption, and complex disease biology. career.bio.mx/call/2025-AI...
🧑🔬 𝟭 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝟮 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗖𝗼-𝗙𝗼𝘂𝗻𝗱𝗲𝗿𝘀 – Experts in computational biology, ML, bioinformatics, language models, encryption, and complex disease biology. career.bio.mx/call/2025-AI...
March 5, 2025 at 5:21 PM
🚀 𝗡𝗘𝗪 𝗖𝗮𝗹𝗹: 𝗦𝘁𝗮𝗿𝘁 𝗬𝗼𝘂𝗿 𝗢𝘄𝗻 𝗔𝗜-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗶𝗻 𝗜𝘀𝗿𝗮𝗲𝗹!🔹 We are looking for:
🧑🔬 𝟭 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝟮 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗖𝗼-𝗙𝗼𝘂𝗻𝗱𝗲𝗿𝘀 – Experts in computational biology, ML, bioinformatics, language models, encryption, and complex disease biology. career.bio.mx/call/2025-AI...
🧑🔬 𝟭 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝟮 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁 𝗖𝗼-𝗙𝗼𝘂𝗻𝗱𝗲𝗿𝘀 – Experts in computational biology, ML, bioinformatics, language models, encryption, and complex disease biology. career.bio.mx/call/2025-AI...
🚀 BioMed X Institute, Barbados & EU join forces! Launching BioMed X Barbados to advance treatments for #cardiometabolic diseases in individuals of African descent. #HealthcareInnovation read our news bio.mx/news/press-r...
BioMed X Launches New Institute in Barbados – BioMed X Institute
BioMed X Institute, in collaboration with the Government of Barbados and the European Commission, is launching BioMed X Barbados, a new research initiative focused on better treatment of cardiometabol...
bio.mx
February 26, 2025 at 9:47 AM
🚀 BioMed X Institute, Barbados & EU join forces! Launching BioMed X Barbados to advance treatments for #cardiometabolic diseases in individuals of African descent. #HealthcareInnovation read our news bio.mx/news/press-r...